Telomir Pharmaceuticals, Inc. TELO

Recent filings and events

• 2026-08-10 Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
• 2026-06-15 Regulation FD disclosure Item 7.01
• 2026-06-08 Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
• 2026-05-20 Regulation FD disclosure Item 7.01
• 2026-04-30 Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
• 2026-04-24 Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
• 2026-04-24 Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01
• 2026-04-24 Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
• 2026-03-31 Other event Item 8.01
• 2026-03-31 Other event Item 8.01
• 2026-03-27 Officer or director change Item 5.02
• 2026-03-27 Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.